Group One Trading
ENTA icon

Group One Trading’s Enanta Pharmaceuticals ENTA Stock Holding History

Group One Trading’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15K Buy
+91
New +$1.22K ﹤0.01% 7195
2025
Q4 		– Sell
-800
Closed -$10.2K – 8384
2025
Q3 		$9.58K Buy
800
+700
+700% +$5.59K ﹤0.01% 7199
2025
Q2 		$756 Buy
+100
New +$602 ﹤0.01% 7609
2021
Q3 		– Sell
-6
Closed -$297 – 8306
2021
Q2 		$0 Hold
6
– – ﹤0.01% 8246
2021
Q1 		$0 Hold
6
– – ﹤0.01% 7676
2020
Q4 		$0 Hold
6
– – ﹤0.01% 6618
2020
Q3 		$0 Hold
6
– – ﹤0.01% 6196
2020
Q2 		$0 Sell
6
-73
-92% -$3.78K ﹤0.01% 5868
2020
Q1 		$4K Buy
+79
New +$4.21K ﹤0.01% 4827
2019
Q4 		– Sell
-56
Closed -$3.47K – 5222
2019
Q3 		$3K Hold
56
– – ﹤0.01% 4851
2019
Q2 		$5K Sell
56
-44
-44% -$3.96K ﹤0.01% 4596
2019
Q1 		$10K Buy
+100
New +$8.97K ﹤0.01% 4268
2018
Q4 		– Sell
-387
Closed -$29.7K – 4988
2018
Q3 		$33K Sell
387
-1,411
-78% -$141K ﹤0.01% 4192
2018
Q2 		$208K Buy
+1,798
New +$179K ﹤0.01% 3019
2018
Q1 		– Sell
-100
Closed -$7.7K – 4946
2017
Q4 		$6K Buy
+100
New +$5.01K ﹤0.01% 4511
2015
Q3 		– Sell
-778
Closed -$35K – 4927
2015
Q2 		$35K Hold
778
– – ﹤0.01% 3746
2015
Q1 		$24K Buy
+778
New +$30.3K ﹤0.01% 3794
2014
Q4 		– Sell
-162
Closed -$6K – 4982
2014
Q3 		$6K Buy
162
+100
+161% +$3.99K ﹤0.01% 4663
2014
Q2 		$3K Buy
62
+40
+182% +$1.53K ﹤0.01% 4914
2014
Q1 		$1K Buy
+22
New +$799 ﹤0.01% 5062

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Group One Trading's ENTA Position: Q1 2026 in Review

Group One Trading opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 91 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #7195 among its holdings. This is a return to the name: Group One Trading previously reported a position in ENTA as recently as Q3 2025.

Group One Trading first reported a position in ENTA in Q1 2014 and has held it in 20 quarters since. The position peaked at $208K in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Group One Trading held 91 shares of Enanta Pharmaceuticals worth $1.15K as of Q1 2026.
  • Enanta Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7195 holding.
  • Group One Trading first reported a position in Enanta Pharmaceuticals in Q1 2014 and has held it in 20 quarters since.
  • Group One Trading's Enanta Pharmaceuticals position peaked at $208K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.